Mannich Base Derived from Lawsone Inhibits PKM2 and Induces Neoplastic Cell Death
2024

Mannich Base Derived from Lawsone Inhibits PKM2 and Induces Neoplastic Cell Death

publication 10 minutes Evidence: moderate

Author Information

Author(s): Rubini-Dias Lucas, Tácio V. A. Fernandes, Michele P. de Souza, Déborah Hottz, Afonso T. Arruda, Amanda de A. Borges, Gabriel Ouverney, Fernando de C. da Silva, Luana da S. M. Forezi, Gabriel Limaverde-Sousa, Bruno K. Robbs

Primary Institution: Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro

Hypothesis

This study aims to investigate whether the Mannich base derived from lawsone (MB-6a) can inhibit PKM2 enzymatic activity and induce cell death in cancer cells.

Conclusion

The study found that MB-6a effectively inhibits PKM2 activity, reduces ATP production, and shows selective cytotoxicity against cancer cells.

Supporting Evidence

  • MB-6a showed selective cytotoxicity against cancer cell lines without affecting normal cells.
  • The selectivity index for MB-6a in SCC-9 was 4.63, indicating high selectivity.
  • MB-6a inhibited PKM2 activity with an IC50 of 1039 nM.
  • ATP production was reduced by approximately 50% upon MB-6a treatment.
  • Molecular docking studies indicated favorable binding of MB-6a to PKM2.

Takeaway

Researchers found that a compound from a plant can stop cancer cells from making energy, which helps them grow. This could be a new way to treat cancer.

Methodology

The study used MTT assays to test the antiproliferative potential of MB-6a in various cancer cell lines and assessed PKM2 inhibition through LDH-coupled assays and ATP production measurements.

Limitations

The study does not explore the long-term effects of MB-6a or its in vivo efficacy.

Statistical Information

P-Value

IC50 = 1039 nM

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/biomedicines12122916

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication